The company's platform utilizes patented drug delivery mechanisms for deep penetration of established therapies that can be delivered to a site of action while avoiding exposure to the rest of the body. Novilla Pharmaceuticals was founded in 2019 and is based in Arlington, Virginia with a laboratory in Cambridge, Massachusetts. The Opioid Epidemic is one of the most significant threats to public health facing the United States. Novilla is addressing this issue by developing an opioid alternative to pain therapeutics through patented drug delivery methods.